National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

pan HER/VEGFR2 receptor tyrosine kinase inhibitor BMS-690154
A pyrrolotriazine-based compound and a pan inhibitor of receptor tyrosine kinases with potential antineoplastic activity. Pan HER/VEGFR2 receptor tyrosine kinase inhibitor BMS-690154 binds to human epidermal growth factor receptors 1 and 2 (HER1, HER2) and vascular endothelial growth factor receptor 2 (VEGFR-2), all three of which are frequently overexpressed by a variety of tumor types. Binding of this agent to these receptors may result in the inhibition of tumor cell proliferation; the inhibition of endothelial cell migration and proliferation and angiogenesis; and tumor cell death. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Code name:BMS-690154



Previous:Pallace, palladium Pd 103, palladium-bacteriopheophorbide, palonosetron hydrochloride, pamidronate disodium
Next:pan-AKT kinase inhibitor GSK690693, Panglobulin, Panhematin, panitumumab, panobinostat

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov